Quality of Life in Patients With Hemorrhagic Telangiectasia
This study aims to understand how Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler's disease, affects people's lives. HHT is a genetic condition that causes blood vessels to form abnormally, often showing up as red spots (telangiectasias) on the skin, especially the face. Many people with HHT also experience anaemia, which can make them look pale and tired. The study wants to explore if these changes in appearance, particularly on the face, make patients feel less confident or have other social difficulties. Researchers will use various questionnaires to collect information about how patients feel, along with some routine health details like blood test results.
At a glance
What is this study about?
Hereditary Hemorrhagic Telangiectasia (HHT), sometimes called Osler's disease, is a condition passed down through families that affects how blood vessels are made. Instead of forming neatly, some blood vessels become tangled or widened, often appearing as small red dots called telangiectasias on the skin, particularly the face. These can also show up in other areas like the nose, causing Nosebleeds, or even in internal organs such as the lungs or stomach.
Living with HHT can sometimes mean dealing with different challenges. For example, many people with HHT experience anaemia, which is when your blood doesn't have enough healthy red blood cells. This can make you feel very tired and look pale. The study is particularly interested in understanding how visible changes, like the red spots on the face, might affect how people feel about their appearance and their confidence in social situations. It's about exploring the 'quality of life' for those with HHT.
To understand this better, researchers will ask participants to complete several questionnaires. These questionnaires are designed to gather information about how people feel about their appearance, their general well-being, and their daily lives. They will also look at some routine health information, like blood test results (especially iron levels), how severe nosebleeds are, and other health habits. The goal is to get a clearer picture of the full impact HHT has on a person's life.
Key takeaways
- The study focuses on understanding how HHT impacts daily life and appearance.
- It uses questionnaires to gather patient feelings and experiences.
- No new treatments or medications are involved.
- Participation primarily means completing forms.
- You must have a confirmed HHT diagnosis and speak German.
- Helping researchers understand HHT better could improve future patient care.
Who may be eligible?
To be part of this study, you need to be at least 18 years old and speak German. You must also be able to understand what the study involves and agree to take part freely. Importantly, you will need to have a confirmed diagnosis of HHT, either through specific medical criteria or genetic testing.
If you don't meet these requirements, for example, if you are under 18, don't speak German, or haven't been diagnosed with HHT, then this particular study would not be suitable for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you speak German?
- Do you have a confirmed diagnosis of HHT (Osler's disease)?
- Are you able to understand and agree to take part in a study?
What does participation involve?
If you decide to take part in this study, you will be primarily answering a series of questionnaires. These will ask about your feelings, your general health, and how HHT affects you. There are no treatments, medications, or extra doctor's visits involved that are not part of your usual care. The total time you'll spend on the study is expected to be minimal, mainly focused on completing the questionnaires. There's no long-term follow-up specifically for this study, as it's about gathering information at one point in time.
Potential risks and benefits
Locations (1)
- Departement of Otorhinolaryngology - Head and Neck Surgery University Hospital EssenVerified postcodeEssen, Germany
Common questions
What is HHT?
HHT, or Hereditary Hemorrhagic Telangiectasia, is a genetic condition that causes blood vessels to form abnormally, often leading to issues like nosebleeds and red spots on the skin.
Why is this study being done?
This study wants to understand how HHT affects people's quality of life, especially how they feel about their appearance and their overall well-being.
What will I have to do if I join?
If you join, you will be asked to fill out some questionnaires about your experiences and feelings related to HHT.
Will I get any medicine or treatment?
No, this study does not involve any new medicines, treatments, or extra medical procedures beyond your usual care. It's purely about collecting information.
Can I leave the study at any time?
Yes, you are free to leave the study at any point, and it won't affect your ongoing medical treatment or care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.